CYD19 (Synonyms: Snail/HDAC-IN-1)

目录号: HY-144315 纯度: 95.48%: FAQs
Data Sheet SDS COA 产品使用指南

摩尔计算器

CYD19 是一种有效的 Snail/HDAC 双靶点抑制剂。CYD19 对 HDAC1 有较强的抑制活性，IC₅₀ 为0.405 μM，对 Snail 有较强的抑制作用，K_d 为 0.18 μM。CYD19 增加 HCT-116 细胞中的组蛋白 H4 乙酰化，并降低 Snail 蛋白的表达，从而诱导细胞凋亡 (apoptosis)。

MCE 的所有产品仅用作科学研究或药证申报，我们不为任何个人用途提供产品和服务

我们将采用定制合成服务的方式为您快速提供所需产品和技术服务

CYD19 Chemical Structure

CAS No. : 2415281-52-4

1. 客户无需承担相应的运输费用。

2. 同一机构（单位）同一产品试用装仅限申领一次，同一机构（单位）一年内

可免费申领三个不同产品的试用装。

3. 试用装只面向终端客户。

规格	价格	是否有货
5 mg	￥1500	In-stock
10 mg	￥2500	In-stock
25 mg	￥5500	In-stock
50 mg		询价
100 mg		询价

or 大包装询价

* Please select Quantity before adding items.

Customer Review

CYD19 相关产品

•相关化合物库:

•同靶点产品:

•同靶点蛋白产品:

查看 HDAC 亚型特异性产品:

查看所有亚型

HDAC HDAC1 HDAC2 HDAC3 HDAC4 HDAC5 HDAC6 HDAC7 HDAC8 HDAC9 HDAC10 HDAC11 HD1 HD2

生物活性
纯度 & 产品资料
参考文献

生物活性

CYD19 is a potent Snail/HDAC dual target inhibitor. CYD19 displays potent inhibitory activity against HDAC1 with an IC₅₀ of 0.405 μM and potent inhibition against Snail with a K_d of 0.18 μM. CYD19 increases histone H4 acetylation in HCT-116 cells and decreases the expression of Snail protein to induce cell apoptosis^[1].

IC₅₀ & Target^[1]

HDAC1

0.405 μM (IC₅₀)

Snail

0.18 μM (Kd)

细胞效力
(Cellular Effect)

Cell Line	Type	Value	Description	References
786-0	GI₅₀	0.466 μM Compound: 9n	Antiproliferative activity against human 786-0 cells assessed as growth inhibition incubated for 72 hrs by luminescence assay Antiproliferative activity against human 786-0 cells assessed as growth inhibition incubated for 72 hrs by luminescence assay	[PMID: 34995925]
A498	GI₅₀	0.623 μM Compound: 9n	Antiproliferative activity against human A498 cells assessed as growth inhibition incubated for 72 hrs by luminescence assay Antiproliferative activity against human A498 cells assessed as growth inhibition incubated for 72 hrs by luminescence assay	[PMID: 34995925]
A549	GI₅₀	0.886 μM Compound: 9n	Antiproliferative activity against human A549 cells assessed as growth inhibition incubated for 72 hrs by luminescence assay Antiproliferative activity against human A549 cells assessed as growth inhibition incubated for 72 hrs by luminescence assay	[PMID: 34995925]
ACHN	GI₅₀	1.24 μM Compound: 9n	Antiproliferative activity against human ACHN cells assessed as growth inhibition incubated for 72 hrs by luminescence assay Antiproliferative activity against human ACHN cells assessed as growth inhibition incubated for 72 hrs by luminescence assay	[PMID: 34995925]
BT-549	GI₅₀	0.296 μM Compound: 9n	Antiproliferative activity against human BT-549 cells assessed as growth inhibition incubated for 72 hrs by luminescence assay Antiproliferative activity against human BT-549 cells assessed as growth inhibition incubated for 72 hrs by luminescence assay	[PMID: 34995925]
CCRF-CEM	GI₅₀	0.411 μM Compound: 9n	Antiproliferative activity against human CCRF-CEM cells assessed as growth inhibition incubated for 72 hrs by luminescence assay Antiproliferative activity against human CCRF-CEM cells assessed as growth inhibition incubated for 72 hrs by luminescence assay	[PMID: 34995925]
COLO 205	GI₅₀	0.296 μM Compound: 9n	Antiproliferative activity against human COLO 205 cells assessed as growth inhibition incubated for 72 hrs by luminescence assay Antiproliferative activity against human COLO 205 cells assessed as growth inhibition incubated for 72 hrs by luminescence assay	[PMID: 34995925]
DU-145	GI₅₀	0.461 μM Compound: 9n	Antiproliferative activity against human DU-145 cells assessed as growth inhibition incubated for 72 hrs by luminescence assay Antiproliferative activity against human DU-145 cells assessed as growth inhibition incubated for 72 hrs by luminescence assay	[PMID: 34995925]
EKVX	GI₅₀	0.919 μM Compound: 9n	Antiproliferative activity against human EKVX cells assessed as growth inhibition incubated for 72 hrs by luminescence assay Antiproliferative activity against human EKVX cells assessed as growth inhibition incubated for 72 hrs by luminescence assay	[PMID: 34995925]
HCC 2998	GI₅₀	0.677 μM Compound: 9n	Antiproliferative activity against human HCC 2998 cells assessed as growth inhibition incubated for 72 hrs by luminescence assay Antiproliferative activity against human HCC 2998 cells assessed as growth inhibition incubated for 72 hrs by luminescence assay	[PMID: 34995925]
HCT-116	IC₅₀	0.0751 μM Compound: 9n	Antiproliferative activity against human HCT-116 cells assessed as cell viability at 1 uM incubated for 72 hrs by luminescence assay Antiproliferative activity against human HCT-116 cells assessed as cell viability at 1 uM incubated for 72 hrs by luminescence assay	[PMID: 34995925]
HCT-116	GI₅₀	0.494 μM Compound: 9n	Antiproliferative activity against human HCT-116 cells assessed as growth inhibition incubated for 72 hrs by luminescence assay Antiproliferative activity against human HCT-116 cells assessed as growth inhibition incubated for 72 hrs by luminescence assay	[PMID: 34995925]
HCT-15	GI₅₀	0.424 μM Compound: 9n	Antiproliferative activity against human HCT-15 cells assessed as growth inhibition incubated for 72 hrs by luminescence assay Antiproliferative activity against human HCT-15 cells assessed as growth inhibition incubated for 72 hrs by luminescence assay	[PMID: 34995925]
HL-60	GI₅₀	0.268 μM Compound: 9n	Antiproliferative activity against human HL-60 cells assessed as growth inhibition incubated for 72 hrs by luminescence assay Antiproliferative activity against human HL-60 cells assessed as growth inhibition incubated for 72 hrs by luminescence assay	[PMID: 34995925]
HOP-62	GI₅₀	0.556 μM Compound: 9n	Antiproliferative activity against human HOP-62 cells assessed as growth inhibition incubated for 72 hrs by luminescence assay Antiproliferative activity against human HOP-62 cells assessed as growth inhibition incubated for 72 hrs by luminescence assay	[PMID: 34995925]
HOP-92	GI₅₀	3.68 μM Compound: 9n	Antiproliferative activity against human HOP-92 cells assessed as growth inhibition incubated for 72 hrs by luminescence assay Antiproliferative activity against human HOP-92 cells assessed as growth inhibition incubated for 72 hrs by luminescence assay	[PMID: 34995925]
Hs-578T	GI₅₀	0.429 μM Compound: 9n	Antiproliferative activity against human Hs-578T cells assessed as growth inhibition incubated for 72 hrs by luminescence assay Antiproliferative activity against human Hs-578T cells assessed as growth inhibition incubated for 72 hrs by luminescence assay	[PMID: 34995925]
HT-29	GI₅₀	0.322 μM Compound: 9n	Antiproliferative activity against human HT-29 cells assessed as growth inhibition incubated for 72 hrs by luminescence assay Antiproliferative activity against human HT-29 cells assessed as growth inhibition incubated for 72 hrs by luminescence assay	[PMID: 34995925]
IGROV-1	GI₅₀	0.558 μM Compound: 9n	Antiproliferative activity against human IGROV-1 cells assessed as growth inhibition incubated for 72 hrs by luminescence assay Antiproliferative activity against human IGROV-1 cells assessed as growth inhibition incubated for 72 hrs by luminescence assay	[PMID: 34995925]
K562	GI₅₀	0.0487 μM Compound: 9n	Antiproliferative activity against human K562 cells assessed as growth inhibition incubated for 72 hrs by luminescence assay Antiproliferative activity against human K562 cells assessed as growth inhibition incubated for 72 hrs by luminescence assay	[PMID: 34995925]
KM12	GI₅₀	0.284 μM Compound: 9n	Antiproliferative activity against human KM12 cells assessed as growth inhibition incubated for 72 hrs by luminescence assay Antiproliferative activity against human KM12 cells assessed as growth inhibition incubated for 72 hrs by luminescence assay	[PMID: 34995925]
LOX IMVI	GI₅₀	0.665 μM Compound: 9n	Antiproliferative activity against human LOX IMVI cells assessed as growth inhibition incubated for 72 hrs by luminescence assay Antiproliferative activity against human LOX IMVI cells assessed as growth inhibition incubated for 72 hrs by luminescence assay	[PMID: 34995925]
M14	GI₅₀	0.289 μM Compound: 9n	Antiproliferative activity against human M14 cells assessed as growth inhibition incubated for 72 hrs by luminescence assay Antiproliferative activity against human M14 cells assessed as growth inhibition incubated for 72 hrs by luminescence assay	[PMID: 34995925]
Malme-3M	GI₅₀	1.83 μM Compound: 9n	Antiproliferative activity against human Malme-3M cells assessed as growth inhibition incubated for 72 hrs by luminescence assay Antiproliferative activity against human Malme-3M cells assessed as growth inhibition incubated for 72 hrs by luminescence assay	[PMID: 34995925]
MCF7	GI₅₀	0.0518 μM Compound: 9n	Antiproliferative activity against human MCF7 cells assessed as growth inhibition incubated for 72 hrs by luminescence assay Antiproliferative activity against human MCF7 cells assessed as growth inhibition incubated for 72 hrs by luminescence assay	[PMID: 34995925]
MDA-MB-231	GI₅₀	0.854 μM Compound: 9n	Antiproliferative activity against human MDA-MB-231 cells assessed as growth inhibition incubated for 72 hrs by luminescence assay Antiproliferative activity against human MDA-MB-231 cells assessed as growth inhibition incubated for 72 hrs by luminescence assay	[PMID: 34995925]
MDA-MB-435	GI₅₀	0.0361 μM Compound: 9n	Antiproliferative activity against human MDA-MB-435 cells assessed as growth inhibition incubated for 72 hrs by luminescence assay Antiproliferative activity against human MDA-MB-435 cells assessed as growth inhibition incubated for 72 hrs by luminescence assay	[PMID: 34995925]
MDA-MB-468	GI₅₀	0.432 μM Compound: 9n	Antiproliferative activity against human MDA-MB-468 cells assessed as growth inhibition incubated for 72 hrs by luminescence assay Antiproliferative activity against human MDA-MB-468 cells assessed as growth inhibition incubated for 72 hrs by luminescence assay	[PMID: 34995925]
MOLT-4	GI₅₀	0.508 μM Compound: 9n	Antiproliferative activity against human MOLT-4 cells assessed as growth inhibition incubated for 72 hrs by luminescence assay Antiproliferative activity against human MOLT-4 cells assessed as growth inhibition incubated for 72 hrs by luminescence assay	[PMID: 34995925]
NCI/ADR-RES	GI₅₀	1.98 μM Compound: 9n	Antiproliferative activity against human NCI/ADR-RES cells assessed as growth inhibition incubated for 72 hrs by luminescence assay Antiproliferative activity against human NCI/ADR-RES cells assessed as growth inhibition incubated for 72 hrs by luminescence assay	[PMID: 34995925]
NCI-H226	GI₅₀	2.7 μM Compound: 9n	Antiproliferative activity against human NCI-H226 cells assessed as growth inhibition incubated for 72 hrs by luminescence assay Antiproliferative activity against human NCI-H226 cells assessed as growth inhibition incubated for 72 hrs by luminescence assay	[PMID: 34995925]
NCI-H23	GI₅₀	0.603 μM Compound: 9n	Antiproliferative activity against human NCI-H23 cells assessed as growth inhibition incubated for 72 hrs by luminescence assay Antiproliferative activity against human NCI-H23 cells assessed as growth inhibition incubated for 72 hrs by luminescence assay	[PMID: 34995925]
NCI-H322M	GI₅₀	1.01 μM Compound: 9n	Antiproliferative activity against human NCI-H322M cells assessed as growth inhibition incubated for 72 hrs by luminescence assay Antiproliferative activity against human NCI-H322M cells assessed as growth inhibition incubated for 72 hrs by luminescence assay	[PMID: 34995925]
NCI-H460	GI₅₀	0.395 μM Compound: 9n	Antiproliferative activity against human NCI-H460 cells assessed as growth inhibition incubated for 72 hrs by luminescence assay Antiproliferative activity against human NCI-H460 cells assessed as growth inhibition incubated for 72 hrs by luminescence assay	[PMID: 34995925]
NCI-H522	GI₅₀	0.0488 μM Compound: 9n	Antiproliferative activity against human NCI-H522 cells assessed as growth inhibition incubated for 72 hrs by luminescence assay Antiproliferative activity against human NCI-H522 cells assessed as growth inhibition incubated for 72 hrs by luminescence assay	[PMID: 34995925]
OVCAR-3	GI₅₀	0.202 μM Compound: 9n	Antiproliferative activity against human OVCAR-3 cells assessed as growth inhibition incubated for 72 hrs by luminescence assay Antiproliferative activity against human OVCAR-3 cells assessed as growth inhibition incubated for 72 hrs by luminescence assay	[PMID: 34995925]
OVCAR-4	GI₅₀	1.66 μM Compound: 9n	Antiproliferative activity against human OVCAR-4 cells assessed as growth inhibition incubated for 72 hrs by luminescence assay Antiproliferative activity against human OVCAR-4 cells assessed as growth inhibition incubated for 72 hrs by luminescence assay	[PMID: 34995925]
OVCAR-5	GI₅₀	0.657 μM Compound: 9n	Antiproliferative activity against human OVCAR-5 cells assessed as growth inhibition incubated for 72 hrs by luminescence assay Antiproliferative activity against human OVCAR-5 cells assessed as growth inhibition incubated for 72 hrs by luminescence assay	[PMID: 34995925]
OVCAR-8	GI₅₀	0.483 μM Compound: 9n	Antiproliferative activity against human OVCAR-8 cells assessed as growth inhibition incubated for 72 hrs by luminescence assay Antiproliferative activity against human OVCAR-8 cells assessed as growth inhibition incubated for 72 hrs by luminescence assay	[PMID: 34995925]
PC-3	GI₅₀	0.355 μM Compound: 9n	Antiproliferative activity against human PC-3 cells assessed as growth inhibition incubated for 72 hrs by luminescence assay Antiproliferative activity against human PC-3 cells assessed as growth inhibition incubated for 72 hrs by luminescence assay	[PMID: 34995925]
RPMI-8226	GI₅₀	0.514 μM Compound: 9n	Antiproliferative activity against human RPMI-8226 cells assessed as growth inhibition incubated for 72 hrs by luminescence assay Antiproliferative activity against human RPMI-8226 cells assessed as growth inhibition incubated for 72 hrs by luminescence assay	[PMID: 34995925]
RXF 393	GI₅₀	0.301 μM Compound: 9n	Antiproliferative activity against human RXF 393 cells assessed as growth inhibition incubated for 72 hrs by luminescence assay Antiproliferative activity against human RXF 393 cells assessed as growth inhibition incubated for 72 hrs by luminescence assay	[PMID: 34995925]
SF-268	GI₅₀	1.12 μM Compound: 9n	Antiproliferative activity against human SF-268 cells assessed as growth inhibition incubated for 72 hrs by luminescence assay Antiproliferative activity against human SF-268 cells assessed as growth inhibition incubated for 72 hrs by luminescence assay	[PMID: 34995925]
SF-295	GI₅₀	0.354 μM Compound: 9n	Antiproliferative activity against human SF-295 cells assessed as growth inhibition incubated for 72 hrs by luminescence assay Antiproliferative activity against human SF-295 cells assessed as growth inhibition incubated for 72 hrs by luminescence assay	[PMID: 34995925]
SF-539	GI₅₀	0.282 μM Compound: 9n	Antiproliferative activity against human SF-539 cells assessed as growth inhibition incubated for 72 hrs by luminescence assay Antiproliferative activity against human SF-539 cells assessed as growth inhibition incubated for 72 hrs by luminescence assay	[PMID: 34995925]
SK-MEL-2	GI₅₀	0.617 μM Compound: 9n	Antiproliferative activity against human SK-MEL-2 cells assessed as growth inhibition incubated for 72 hrs by luminescence assay Antiproliferative activity against human SK-MEL-2 cells assessed as growth inhibition incubated for 72 hrs by luminescence assay	[PMID: 34995925]
SK-MEL-28	GI₅₀	2.83 μM Compound: 9n	Antiproliferative activity against human SK-MEL-28 cells assessed as growth inhibition incubated for 72 hrs by luminescence assay Antiproliferative activity against human SK-MEL-28 cells assessed as growth inhibition incubated for 72 hrs by luminescence assay	[PMID: 34995925]
SK-MEL-5	GI₅₀	0.334 μM Compound: 9n	Antiproliferative activity against human SK-MEL-5 cells assessed as growth inhibition incubated for 72 hrs by luminescence assay Antiproliferative activity against human SK-MEL-5 cells assessed as growth inhibition incubated for 72 hrs by luminescence assay	[PMID: 34995925]
SK-OV-3	GI₅₀	0.339 μM Compound: 9n	Antiproliferative activity against human SK-OV-3 cells assessed as growth inhibition incubated for 72 hrs by luminescence assay Antiproliferative activity against human SK-OV-3 cells assessed as growth inhibition incubated for 72 hrs by luminescence assay	[PMID: 34995925]
SN12C	GI₅₀	1.25 μM Compound: 9n	Antiproliferative activity against human SN12C cells assessed as growth inhibition incubated for 72 hrs by luminescence assay Antiproliferative activity against human SN12C cells assessed as growth inhibition incubated for 72 hrs by luminescence assay	[PMID: 34995925]
SNB-19	GI₅₀	0.536 μM Compound: 9n	Antiproliferative activity against human SNB-19 cells assessed as growth inhibition incubated for 72 hrs by luminescence assay Antiproliferative activity against human SNB-19 cells assessed as growth inhibition incubated for 72 hrs by luminescence assay	[PMID: 34995925]
SNB-75	GI₅₀	0.198 μM Compound: 9n	Antiproliferative activity against human SNB-75 cells assessed as growth inhibition incubated for 72 hrs by luminescence assay Antiproliferative activity against human SNB-75 cells assessed as growth inhibition incubated for 72 hrs by luminescence assay	[PMID: 34995925]
SR	GI₅₀	0.068 μM Compound: 9n	Antiproliferative activity against human SR cells assessed as growth inhibition incubated for 72 hrs by luminescence assay Antiproliferative activity against human SR cells assessed as growth inhibition incubated for 72 hrs by luminescence assay	[PMID: 34995925]
SW-620	GI₅₀	0.426 μM Compound: 9n	Antiproliferative activity against human SW-620 cells assessed as growth inhibition incubated for 72 hrs by luminescence assay Antiproliferative activity against human SW-620 cells assessed as growth inhibition incubated for 72 hrs by luminescence assay	[PMID: 34995925]
T47D	GI₅₀	1.12 μM Compound: 9n	Antiproliferative activity against human T47D cells assessed as growth inhibition incubated for 72 hrs by luminescence assay Antiproliferative activity against human T47D cells assessed as growth inhibition incubated for 72 hrs by luminescence assay	[PMID: 34995925]
TK-10	GI₅₀	1.21 μM Compound: 9n	Antiproliferative activity against human TK-10 cells assessed as growth inhibition incubated for 72 hrs by luminescence assay Antiproliferative activity against human TK-10 cells assessed as growth inhibition incubated for 72 hrs by luminescence assay	[PMID: 34995925]
U-251	GI₅₀	0.343 μM Compound: 9n	Antiproliferative activity against human U-251 cells assessed as growth inhibition incubated for 72 hrs by luminescence assay Antiproliferative activity against human U-251 cells assessed as growth inhibition incubated for 72 hrs by luminescence assay	[PMID: 34995925]
UACC-257	GI₅₀	3.69 μM Compound: 9n	Antiproliferative activity against human UACC-257 cells assessed as growth inhibition incubated for 72 hrs by luminescence assay Antiproliferative activity against human UACC-257 cells assessed as growth inhibition incubated for 72 hrs by luminescence assay	[PMID: 34995925]
UACC-62	GI₅₀	0.347 μM Compound: 9n	Antiproliferative activity against human UACC-62 cells assessed as growth inhibition incubated for 72 hrs by luminescence assay Antiproliferative activity against human UACC-62 cells assessed as growth inhibition incubated for 72 hrs by luminescence assay	[PMID: 34995925]
UO-31	GI₅₀	1.33 μM Compound: 9n	Antiproliferative activity against human UO-31 cells assessed as growth inhibition incubated for 72 hrs by luminescence assay Antiproliferative activity against human UO-31 cells assessed as growth inhibition incubated for 72 hrs by luminescence assay	[PMID: 34995925]

体外研究
(In Vitro)

CYD19 (compound 9n) shows antiproliferative activity in HCT-116 cell lines with an IC₅₀ of 0.0751 μM. CYD19 shows a good inhibitory effect on NCI–H522 (GI₅₀=0.0488 μM), MDA-MB-435 (GI₅₀=0.0361 μM), and MCF7 (GI₅₀=0.0518 μM)^[1].

MCE has not independently confirmed the accuracy of these methods. They are for reference only.

分子量

488.54

Formula

C₂₄H₂₁FN₈OS

CAS 号

2415281-52-4

性状

固体

颜色

Light yellow to light brown

运输条件

Room temperature in continental US; may vary elsewhere.

储存方式

4°C, protect from light

*In solvent : -80°C, 6 months; -20°C, 1 month (protect from light)

溶解性数据

细胞实验：

DMSO 中的溶解度 : 125 mg/mL (255.86 mM; 超声助溶 (<60°C); 吸湿的 DMSO 对产品的溶解度有显著影响，请使用新开封的 DMSO)

配制储备液

浓度溶剂体积质量	1 mg	5 mg	10 mg

1 mM	2.0469 mL	10.2346 mL	20.4692 mL
5 mM	0.4094 mL	2.0469 mL	4.0938 mL
10 mM	0.2047 mL	1.0235 mL	2.0469 mL

查看完整储备液配制表

* 请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液；一旦配成溶液，请分装保存，避免反复冻融造成的产品失效。
储备液的保存方式和期限：-80°C, 6 months; -20°C, 1 month (protect from light)。-80°C储存时，请在6个月内使用，-20°C储存时，请在1个月内使用。

摩尔计算器
稀释计算器

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

Concentration _(start) × Volume _(start) = Concentration _(final) × Volume _(final)

This equation is commonly abbreviated as: C₁V₁ = C₂V₂

浓度 _(start)

体积 _(start)

浓度 _(final)

体积 _(final)

动物溶解方案计算器

请输入动物实验的基本信息：

给药剂量

mg/kg

动物的平均体重

每只动物的给药体积

μL

动物数量

只

由于实验过程有损耗，建议您多配一只动物的量

计算结果

工作液所需浓度 : mg/mL

纯度 & 产品资料

纯度: 95.48%

选择批次：

Data Sheet (599 KB) SDS (251 KB)

COA (289 KB) HNMR (299 KB) LCMS (103 KB)

产品使用指南 (1538 KB)

参考文献

[1]. Cui H, et al. Design and synthesis of dual inhibitors targeting snail and histone deacetylase for the treatment of solid tumour cancer. Eur J Med Chem. 2022;229:114082. [Content Brief]

CYD19 相关分类

完整储备液配制表

可选溶剂	浓度溶剂体积质量	1 mg	5 mg	10 mg	25 mg

DMSO	1 mM	2.0469 mL	10.2346 mL	20.4692 mL	51.1729 mL
	5 mM	0.4094 mL	2.0469 mL	4.0938 mL	10.2346 mL
	10 mM	0.2047 mL	1.0235 mL	2.0469 mL	5.1173 mL
	15 mM	0.1365 mL	0.6823 mL	1.3646 mL	3.4115 mL
	20 mM	0.1023 mL	0.5117 mL	1.0235 mL	2.5586 mL
	25 mM	0.0819 mL	0.4094 mL	0.8188 mL	2.0469 mL
	30 mM	0.0682 mL	0.3412 mL	0.6823 mL	1.7058 mL
	40 mM	0.0512 mL	0.2559 mL	0.5117 mL	1.2793 mL
	50 mM	0.0409 mL	0.2047 mL	0.4094 mL	1.0235 mL
	60 mM	0.0341 mL	0.1706 mL	0.3412 mL	0.8529 mL
	80 mM	0.0256 mL	0.1279 mL	0.2559 mL	0.6397 mL
	100 mM	0.0205 mL	0.1023 mL	0.2047 mL	0.5117 mL

Help & FAQs

Do most proteins show cross-species activity?
Species cross-reactivity must be investigated individually for each product. Many human cytokines will produce a nice response in mouse cell lines, and many mouse proteins will show activity on human cells. Other proteins may have a lower specific activity when used in the opposite species.

Keywords:

CYD192415281-52-4Snail/HDAC-IN-1CYD 19CYD-19HDACHistone deacetylasesantiproliferative activityHCT-116 cellsNCI–H522MCF7histone H4 acetylationtumorSnailHDAC1Inhibitorinhibitorinhibit

产品名称：			* 需求量：
* 客户姓名：			* Email：
* 电话：			* 公司或机构名称：
留言给我们：

产品名称：			* Lot #：
* 客户姓名：			* Email：
电话：			* 部门：
* 公司或机构名称：
留言给我们：

MedChemExpress (MCE) 只为有资质的科研机构、医药企业基于科学研究或药证申报的用途提供医药研发服务，不为任何个人或者非科研性质的、非用于药证申报使用等其他用途提供服务。	站点地图隐私声明
沪ICP备15051369号-4 上海工商沪公网安备31011502019417 沪(浦)应急管危经许[2021]201709(QFYS) 营业执照（三证合一）
Copyright © 2013-2024 MedChemExpress. All Rights Reserved.

CYD19 (Synonyms: Snail/HDAC-IN-1)

Customer Review

CYD19 相关产品

•相关化合物库:

•同靶点产品:

•同靶点蛋白产品:

查看 HDAC 亚型特异性产品:

生物活性

纯度 & 产品资料

参考文献

摩尔计算器

稀释计算器

CYD19 相关分类

完整储备液配制表

Keywords:

您最近查看的产品:

热门区域

A

B

C

F

G

H

J

L

N

Q

S

T

X

Y

Z

姓名
邮箱 *

Sorry, but the email address you supplied was invalid.

CYD19 (Synonyms: Snail/HDAC-IN-1)

Customer Review

CYD19 相关抗体

CYD19 相关产品

•相关化合物库:

•同靶点产品:

•同靶点蛋白产品:

查看 HDAC 亚型特异性产品:

生物活性

纯度 & 产品资料

参考文献

CYD19 相关抗体:

摩尔计算器

稀释计算器

CYD19 相关分类

完整储备液配制表

Keywords:

您最近查看的产品:

Request for HNMR Report

Request for HNMR Report

热门区域

A

B

C

F

G

H

J

L

N

Q

S

T

X

Y

Z